More than two-thirds of BPES patients carry intragenic FOXL2 mutations and one-third of mutations in the FOXL2 coding region are expansions of the polyalanine tract, from 14 to 24 residues (2,3). Here, FOXL2 is linked to blepharophimosis, ptosis, and epicanthus inversus syndrome.